�ݺ�ߣshows by User: ManishRajput58

�ݺ�ߣshows by User: ManishRajput58 / http://www.slideshare.net/images/logo.gif �ݺ�ߣshows by User: ManishRajput58 / Sat, 20 Apr 2019 06:26:20 GMT �ݺ�ߣShare feed for �ݺ�ߣshows by User: ManishRajput58 Thin layer chromatography. (TLC) /slideshow/thin-layer-chromatography-tlc-141390147/141390147 tlc-190420062620
chromatography, principle, adsorbent of TLC, mobile phase of TLC, techniques in TLC, preparation of TLC plate, standards for TLC, advantages, disadvantages of TLC, Application of TLC.]]>
chromatography, principle, adsorbent of TLC, mobile phase of TLC, techniques in TLC, preparation of TLC plate, standards for TLC, advantages, disadvantages of TLC, Application of TLC.]]> Sat, 20 Apr 2019 06:26:20 GMT /slideshow/thin-layer-chromatography-tlc-141390147/141390147 ManishRajput58@slideshare.net(ManishRajput58) Thin layer chromatography. (TLC) ManishRajput58 chromatography, principle, adsorbent of TLC, mobile phase of TLC, techniques in TLC, preparation of TLC plate, standards for TLC, advantages, disadvantages of TLC, Application of TLC. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/tlc-190420062620-thumbnail.jpg?width=120&height=120&fit=bounds" /> chromatography, principle, adsorbent of TLC, mobile phase of TLC, techniques in TLC, preparation of TLC plate, standards for TLC, advantages, disadvantages of TLC, Application of TLC.

Thin layer chromatography. (TLC) from Manish Rajput

]]> 17262 4 https://cdn.slidesharecdn.com/ss_thumbnails/tlc-190420062620-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Characterization of Nanoparticles. /slideshow/characterization-of-nanoparticles-141389864/141389864 mol-190420062123
Nanoparticles, characterization, particle size, surface morphology, density, mol. weight, drug entrapment efficiency, kinetic study, stability of nanoparticles, in-vitro release study of nanoparticles, liposomes, lamellarity, phase behaviour. ]]>
Nanoparticles, characterization, particle size, surface morphology, density, mol. weight, drug entrapment efficiency, kinetic study, stability of nanoparticles, in-vitro release study of nanoparticles, liposomes, lamellarity, phase behaviour. ]]> Sat, 20 Apr 2019 06:21:23 GMT /slideshow/characterization-of-nanoparticles-141389864/141389864 ManishRajput58@slideshare.net(ManishRajput58) Characterization of Nanoparticles. ManishRajput58 Nanoparticles, characterization, particle size, surface morphology, density, mol. weight, drug entrapment efficiency, kinetic study, stability of nanoparticles, in-vitro release study of nanoparticles, liposomes, lamellarity, phase behaviour. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/mol-190420062123-thumbnail.jpg?width=120&height=120&fit=bounds" /> Nanoparticles, characterization, particle size, surface morphology, density, mol. weight, drug entrapment efficiency, kinetic study, stability of nanoparticles, in-vitro release study of nanoparticles, liposomes, lamellarity, phase behaviour.

Characterization of Nanoparticles. from Manish Rajput

]]> 21557 9 https://cdn.slidesharecdn.com/ss_thumbnails/mol-190420062123-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Investigational new drug (IND) /slideshow/investigational-new-drug-ind-141389561/141389561 investigationalnewdrugind-190420061758
drug development, IND, withdrawl of IND, exemption, IND review, ]]>
drug development, IND, withdrawl of IND, exemption, IND review, ]]> Sat, 20 Apr 2019 06:17:58 GMT /slideshow/investigational-new-drug-ind-141389561/141389561 ManishRajput58@slideshare.net(ManishRajput58) Investigational new drug (IND) ManishRajput58 drug development, IND, withdrawl of IND, exemption, IND review, <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/investigationalnewdrugind-190420061758-thumbnail.jpg?width=120&height=120&fit=bounds" /> drug development, IND, withdrawl of IND, exemption, IND review,

Investigational new drug (IND) from Manish Rajput

]]> 14338 4 https://cdn.slidesharecdn.com/ss_thumbnails/investigationalnewdrugind-190420061758-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Buccal drug delivery system. /slideshow/buccal-drug-delivery-system-141389132/141389132 ddspresentation-190420061340
theories of bioadhesion or mucoadhesion, advantages and disadvantages of buccal delivery, mechanism of drug permeation, ]]>
theories of bioadhesion or mucoadhesion, advantages and disadvantages of buccal delivery, mechanism of drug permeation, ]]> Sat, 20 Apr 2019 06:13:40 GMT /slideshow/buccal-drug-delivery-system-141389132/141389132 ManishRajput58@slideshare.net(ManishRajput58) Buccal drug delivery system. ManishRajput58 theories of bioadhesion or mucoadhesion, advantages and disadvantages of buccal delivery, mechanism of drug permeation, <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/ddspresentation-190420061340-thumbnail.jpg?width=120&height=120&fit=bounds" /> theories of bioadhesion or mucoadhesion, advantages and disadvantages of buccal delivery, mechanism of drug permeation,

Buccal drug delivery system. from Manish Rajput

]]> 1448 4 https://cdn.slidesharecdn.com/ss_thumbnails/ddspresentation-190420061340-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Regulatory provision related to manufacture of cosmetic /slideshow/regulatory-provision-related-to-manufacture-of-cosmetic/141388565 cosmeticppt-190420060721
cosmetic, regulatory provision, schedule M, condition of licence, schedule U, prohibition of certain cosmetics, misbranded and spurious cosmetics, loan licence, offences and penalties, ]]>
cosmetic, regulatory provision, schedule M, condition of licence, schedule U, prohibition of certain cosmetics, misbranded and spurious cosmetics, loan licence, offences and penalties, ]]> Sat, 20 Apr 2019 06:07:21 GMT /slideshow/regulatory-provision-related-to-manufacture-of-cosmetic/141388565 ManishRajput58@slideshare.net(ManishRajput58) Regulatory provision related to manufacture of cosmetic ManishRajput58 cosmetic, regulatory provision, schedule M, condition of licence, schedule U, prohibition of certain cosmetics, misbranded and spurious cosmetics, loan licence, offences and penalties, <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/cosmeticppt-190420060721-thumbnail.jpg?width=120&height=120&fit=bounds" /> cosmetic, regulatory provision, schedule M, condition of licence, schedule U, prohibition of certain cosmetics, misbranded and spurious cosmetics, loan licence, offences and penalties,

Regulatory provision related to manufacture of cosmetic from Manish Rajput

]]> 23738 4 https://cdn.slidesharecdn.com/ss_thumbnails/cosmeticppt-190420060721-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Quality by design in pharmaceutical development /slideshow/quality-by-design-in-pharmaceutical-development-141388093/141388093 caddppt-190420060038
Quality by design, tools, risk assessment, control strategy, risk assessment methodology, application of Qbd, ]]>
Quality by design, tools, risk assessment, control strategy, risk assessment methodology, application of Qbd, ]]> Sat, 20 Apr 2019 06:00:38 GMT /slideshow/quality-by-design-in-pharmaceutical-development-141388093/141388093 ManishRajput58@slideshare.net(ManishRajput58) Quality by design in pharmaceutical development ManishRajput58 Quality by design, tools, risk assessment, control strategy, risk assessment methodology, application of Qbd, <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/caddppt-190420060038-thumbnail.jpg?width=120&height=120&fit=bounds" /> Quality by design, tools, risk assessment, control strategy, risk assessment methodology, application of Qbd,

Quality by design in pharmaceutical development from Manish Rajput

]]> 42799 5 https://cdn.slidesharecdn.com/ss_thumbnails/caddppt-190420060038-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Drug interaction /slideshow/drug-interaction-141387321/141387321 biopharmppt-190420054955
Drug interaction, Pharmacokinetic, protein binding of drug and effect of tissue binding interaction.]]>
Drug interaction, Pharmacokinetic, protein binding of drug and effect of tissue binding interaction.]]> Sat, 20 Apr 2019 05:49:55 GMT /slideshow/drug-interaction-141387321/141387321 ManishRajput58@slideshare.net(ManishRajput58) Drug interaction ManishRajput58 Drug interaction, Pharmacokinetic, protein binding of drug and effect of tissue binding interaction. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/biopharmppt-190420054955-thumbnail.jpg?width=120&height=120&fit=bounds" /> Drug interaction, Pharmacokinetic, protein binding of drug and effect of tissue binding interaction.

Drug interaction from Manish Rajput

]]> 6515 8 https://cdn.slidesharecdn.com/ss_thumbnails/biopharmppt-190420054955-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 https://cdn.slidesharecdn.com/profile-photo-ManishRajput58-48x48.jpg?cb=1689101739 https://cdn.slidesharecdn.com/ss_thumbnails/tlc-190420062620-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/thin-layer-chromatography-tlc-141390147/141390147 Thin layer chromatogra... https://cdn.slidesharecdn.com/ss_thumbnails/mol-190420062123-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/characterization-of-nanoparticles-141389864/141389864 Characterization of Na... https://cdn.slidesharecdn.com/ss_thumbnails/investigationalnewdrugind-190420061758-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/investigational-new-drug-ind-141389561/141389561 Investigational new dr...